To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Biogen is set to receive as much as $250 million in funding to develop a late-stage experimental lupus ...

Cambridge, Mass.-based Biogen had net income of $266.8 million, or $1.83 a share, for the quarter, up from $249.7 million, or $1.71 a share, a year ago. Adjusted for one-time items, EPS came to $3 ...

and gain approval in Europe or Asia, it could dramatically increase revenue. The market for Alzheimer's drugs is already estimated at $5.2 billion and could almost double by 2030. Biogen ...

Biogen has announced plans to establish a new global headquarters and innovation hub in Cambridge, Mass., which will integrate its research and development, technical operations, and commercial teams ...

Biogen plans to relocate Cambridge-based employees to the new site in 2028 CAMBRIDGE, Mass., March 24, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced plans for its new global ...